“Primary Mode Of Action” Reg To Facilitate Review Center Assignment Of Combo Products
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s proposed rule defines primary mode as “the single mode of action of a combination product that provides the most important therapeutic action of the combination product.”